期刊文献+

2型糖尿病合并冠心病中医证型与血浆HCY、hs-CRP相关性的研究 被引量:11

Research on the Relationship among Plasma HCY,CRP and TCM Syndrome of patients with Type 2 Diabetes and CAD
下载PDF
导出
摘要 目的探讨2型糖尿病(T2DM)并冠心病(CAD)的中医证型与HCY和Hs-CRP的关系。方法选择T2DM并CAD患者82例,中医辨证分为痰瘀互阻证、寒凝血瘀证、肾阳虚衰证3个证型,另设健康对照组30例,各组分别测定血浆高敏C反应蛋白(hs-CRP)、血浆同型半胱氨酸(HCY)水平,并进行组间比较。结果与健康对照组相比,痰瘀互阻组及寒凝血瘀组、肾阳虚衰组各组HCY水平、hs-CRP水平明显增高;与肾阳虚衰组相比,痰瘀互阻组和寒凝血瘀组HCY水平、hs-CRP水平均明显增高(P均<0.05);痰瘀互阻组和寒凝血瘀组之间比较无明显差异(P>0.05)。结论血浆HCY、hs-CRP水平与T2DM合并CAD中医各证型之间有相关性,有可能作为T2DM合并CAD中医临床辨证论治的客观依据。 Objective:To study the HCY and hs-CRP in each TCM type of the patients with type 2 diabetes and CAD.Methods:82 cases of T2DM and CAD were divided into 3 Chinese medicine syndrome groups including of the phlegm and blood stasis transimpedance syndrome,the blood stasis due to cold stagnation syndrome and the kidney-yang deficiency syndrome in addition to normol control group with 30 cases.The fasting plasma levels of HCY and hs-CRP were detected and analyzed among these groups.Results:HCY and hs-CRP levels in the all of the TCM syndrome types of T2DM and CAD patients were higher than those in the healthy control significantly.HCY and hs-CRP levels in the syndrome of phlegm and blood stasis transimpedance were higher than those in the TCM syndrome of kidney-yang deficiency significantly(P 均0.05).There was no significant difference of HCY and hs-CRP levels between the syndrome of phlegm and blood stasis transimpedance and blood stasis due to cold stagnation(P 0.05).Conclusion:There is correlation between the plasma levels of HCY,hs-CRP and the TCM syndrome types of T2DM and CAD patients.The level of plasma HCY,hs-CRP may serve as a sensitive indicator for TCM syndrome tapes diagnosis.
出处 《中国中医急症》 2013年第7期1144-1146,共3页 Journal of Emergency in Traditional Chinese Medicine
基金 四川省中医药管理局立项资助课题(2012-B-072)
关键词 2型糖尿病 冠心病 中医证型 同型半胱氨酸 C反应蛋白 Type 2 diabetes Coronary artery disease TCM syndrome Homocysteine High C-reactive protein
  • 相关文献

参考文献6

二级参考文献29

  • 1万海同,杨进.论养阴是治疗血瘀证的重要法则[J].中医杂志,1996,37(1):8-11. 被引量:59
  • 2[2]Malinow MR. Plasma homocysteine: A risk factor for arterial occlusive disease. J Nutr, 1996, 126: 1238-1243.
  • 3[3]Buysschaert M, Dramais AS, Wallemacq PE, et al. Hyperhomocysteinemia in type2 diabetes: relationship to macroangiopathy, nephropathy and insulin resistance. Diabetes Care, 2000,23: 1816-1822.
  • 4[5]Fonseca VA, Mudaliar S, Schmidt B, et al. Plasma homocysteine concentration are regulated by acute hyperinsulinemia in nondiabetic but not type2 diabetic subjects. Metabolism, 1998, 47: 686-689.
  • 5[6]Idzior-WaluS B, CieSlik G. Chronic complication of diabetes and homocysteine. Przegl Lek, 2000, 57: 732-735.
  • 6Hoogeveen E K,Arterioscler Thromb Vasc Biol,1998年,18卷,133页
  • 7Aronow W S,Am J Cardiol,1997年,79卷,1432页
  • 8Boushey C J,JAMA,1995年,274卷,1049页
  • 9Nishinaga M,J Clin Invest,1993年,92卷,381页
  • 10Taylor L Mjr,J Vasc Surg,1991年,13卷,128页

共引文献192

同被引文献149

引证文献11

二级引证文献53

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部